Photodynamic Hijacking of APE1 Converts Tumor Defenses into Therapeutic Vulnerabilities via a Bidirectionally Gated Prodrug
- 23 September 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (39) , 42416-42431
Abstract
Photodynamic therapy (PDT) for melanoma is chronically undermined by adaptive resistance, a long-overlooked challenge rooted in coordinated antioxidant buffering and DNA repair defenses. Herein, we propose a novel photodynamic sabotage approach that converts tumor defenses into therapeutic vulnerabilities by hijacking one important defense hub, the APE1 protein. This was achieved through creating a bidirectionally gated theranostic prodrug, APE-BDP, which covalently links an iodine-engineered BODIPY to the APE1 inhibitor CRT through a photocleavable bridge. Beyond pioneering the master regulator APE1, as a photodynamic target, the molecular design strategically repurposes the inherent nitro group on CRT as an endogenous quencher that establishes a photoinduced electron transfer process to silence the iodinated BODIPY. Meanwhile, the steric bulk of the conjugate concurrently physically blocks the CRT–APE1 engagement. This bidirectional gating mechanism ensures reciprocal deactivation in the dark. A single green light trigger initiates near-instantaneous (∼100% within minutes) and synchronous liberation of both warheads, enabling a cooperative dual assault that potently disrupts redox homeostasis and inactivates the APE1-mediated DNA repair machinery. This concerted hijacking of the defense network within the tumor triggers multiple cell death pathways. After formulation into a dissolvable microneedle patch for localized delivery, the system effectively suppressed tumor growth in melanoma models with minimal systemic toxicity. This work establishes that the photodynamic hijacking of key regulatory proteins via intelligent molecular engineering offers a potential design strategy to subvert PDT treatment resistance.Keywords
Funding Information
- National Research Foundation of Korea (RS-2018-NR031064)
- National Research Foundation of Korea (RS-2023-00217701)
- National Research Foundation of Korea (RS-2024-00407093)
- China Postdoctoral Science Foundation (2024M752118)
- Young Scientists Fund of the National Natural Science Foundation of China (22408232)
- National Natural Science Foundation of China (NSFC) (22090010)
- National Natural Science Foundation of China (NSFC) (22378051)
- National Natural Science Foundation of China (NSFC) (22525803)
This publication has 64 references indexed in Scilit:
- Unlocking the potential of iridium-osmium carbolong conjugates: a high-performance photocatalyst for melanoma therapyScience China Chemistry, 2025
- Cryoshocked Adipocytes Mediated Dual‐Modal Strategy Combining Photodynamic Therapy and Triptolide Palmitate for Pulmonary Metastatic Melanoma TreatmentAdvanced Science, 2025
- A One Stone Three Birds Paradigm of Photon‐Driven Pyroptosis Dye for Amplifying Tumor ImmunotherapyAdvanced Science, 2025
- Photon‐Driven Dye Induction Pyroptosis: An Emerging Anti‐Tumor Immunotherapy ParadigmAngewandte Chemie International Edition, 2024
- Boronophenylalanine‐Containing Polydopamine Nanoparticles for Enhanced Combined Boron Neutron Capture Therapy and Photothermal Therapy for Melanoma TreatmentAdvanced Functional Materials, 2024
- Remote Control of Energy Transformation‐Based Cancer Imaging and TherapyAdvanced Materials, 2024
- The APE1/REF-1 and the hallmarks of cancerMolecular Biology Reports, 2024
- DNA damage response inhibition‐based combination therapies in cancer treatment: Recent advances and future directionsAging and Cancer, 2022
- Se-sensitized NIR hot band absorption photosensitizer for anti-Stokes excitation deep photodynamic therapyScience China Chemistry, 2022
- Tailored Engineering of Novel Xanthonium Polymethine Dyes for Synergetic PDT and PTT Triggered by 1064 nm Laser toward Deep‐Seated TumorsSmall, 2021